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Abstract. 
 
The chemokine receptor CXCR4 is required, 
together with CD4, for entry by some isolates of HIV-1, 
particularly those that emerge late in infection. The use 
of CXCR4 by these viruses likely has profound effects 
on viral host range and correlates with the evolution of 
immunodeficiency. Stromal cell-derived factor-1 (SDF-1), 
the ligand for CXCR4, can inhibit infection by CXCR4-
dependent viruses. To understand the mechanism of 
this inhibition, we used a monoclonal antibody that is 
specific for CXCR4 to analyze the effects of phorbol es-
ters and SDF-1 on surface expression of CXCR4. On 
human T cell lines SupT1 and BC7, CXCR4 undergoes 
slow constitutive internalization (1.0% of the cell sur-
face pool/min). Addition of phorbol esters increased 
this endocytosis rate 
 
.
 
6-fold and reduced cell surface 
CXCR4 expression by 60 to 90% over 120 min. CXCR4 
was internalized through coated pits and coated vesi-
cles and subsequently localized in endosomal compart-
ments from where it could recycle to the cell surface af-
ter removal of the phorbol ester. SDF-1 also induced 
 
the rapid down modulation (half time 
 
z
 
5 min) of 
CXCR4. Using mink lung epithelial cells expressing 
CXCR4 and a COOH-terminal deletion mutant of 
CXCR4, we found that an intact cytoplasmic COOH-
terminal domain was required for both PMA and 
ligand-induced CXCR4 endocytosis. However, experi-
ments using inhibitors of protein kinase C indicated 
that SDF-1 and phorbol esters trigger down modulation 
through different cellular mechanisms.
SDF-1 inhibited HIV-1 infection of mink cells ex-
pressing CD4 and CXCR4. The inhibition of infection 
was less efficient for CXCR4 lacking the COOH-termi-
nal domain, suggesting at least in part that SDF-1 inhi-
bition of virus infection was mediated through ligand-
induced internalization of CXCR4. Significantly, ligand 
induced internalization of CXCR4 but not CD4, sug-
gesting that CXCR4 and CD4 do not normally physi-
cally interact on the cell surface. Together these studies 
indicate that endocytosis can regulate the cell-surface 
expression of CXCR4 and that SDF-1–mediated down 
regulation of cell-surface coreceptor expression con-
tributes to chemokine-mediated inhibition of HIV in-
fection. 
 
(
 
a
 
) and CC (
 
b
 
) families of inflammatory chemokines (for
review see 42, 52, 54). Initially, the CXC chemokine recep-
tor CXCR4 (previously termed LESTR, HUMSTER, and
Fusin [21, 37]) was identified as a coreceptor, together
with CD4, for the entry of T cell line–adapted human im-
munodeficiency virus (HIV)
 
1
 
-1 viruses (6, 21). Subse-
quently, the CC chemokine receptor CCR5 was found to
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Abbreviations used in this paper
 
: HA, hemagglutinin; HIV, human im-
munodeficiency virus; MIP, macrophage inflammatory peptide; PDB,
phorbol dibutyrate; SDF, stromal cell–derived factor.
 
S
 
everal
 
 members of the family of leukocyte chemo-
kine receptors have been implicated in the fusion
and entry of human and simian immunodeficiency
viruses. Chemokine receptors are members of the super-
family of seven transmembrane domain, G protein-coupled
receptors that bind small peptides of the so-called CXC
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be required for the entry of macrophage tropic viruses (10,
14, 18). Other chemokine receptors (CCR3, CCR2b, and
CCR1) have been implicated in the entry of dual (10, 17)
and neurotropic viruses (28), while CXCR4, CCR3, and an
orphan receptor VT28 can mediate the entry of CD4-inde-
pendent strains of HIV-2 (20, 55; for an extensive review
of HIV coreceptor usage see 40). The use of particular
chemokine receptors by HIV-1 may have important bio-
logical consequences not only for the viral host range, but
also for pathogenesis, since viruses isolated in the initial
stages of infection primarily use CCR5, while those iso-
lated from patients with advanced immunodeficiency may
use CXCR4 in addition to, or in place of, CCR5 (13).
The precise role of chemokine receptors in virus entry is
unclear. The initial interaction of the viral envelope pro-
tein (Env) with CD4 is believed to induce conformational
changes in Env (19, 39, 57) that facilitate an interaction
with the chemokine receptor (62, 64) and assembly of a tri-
molecular complex of CD4, chemokine receptor, and Env
(36). The interaction of Env with both CD4 and CXCR4
appears to be crucial for the events that lead to viral fusion
and entry into the cell. Significantly, the CC chemokines,
macrophage inflammatory polypeptide (MIP)-1
 
a
 
, MIP1
 
b
 
,
and RANTES (regulated on activation normal T cell ex-
pressed and secreted) can inhibit the entry of macrophage
tropic HIV-1 isolates into CCR5-positive target cells (12)
and stromal cell–derived factor (SDF)-1, the ligand for
CXCR4, can inhibit infection of at least some T cell line-
adapted viruses (7, 45). The mechanism through which
these agents inhibit infection is unclear. The chemokines
could inhibit viral entry by blocking the interaction of the
Env with the chemokine receptor (62, 64). Alternatively,
as observed with other G protein–coupled receptors (33,
56, 61, 63), the ligand may induce internalization, thereby
preventing assembly of the fusion complex.
We previously described a murine monoclonal antibody,
12G5, that is specific for CXCR4 (20). Among a panel of
CHO cell lines that stably expressed CXC (CXCR1, CXCR2,
and CXCR4) and CC (CCR1-5) receptors, 12G5 reacted
only with cells that expressed CXCR4. Subsequent studies
have mapped the 12G5-binding site to a conformational
epitope that includes the second extracellular loop of CXCR4
(Hoxie, J.A., unpublished results). In this study, we have
used 12G5 to evaluate the effects of phorbol esters and
SDF-1 on CXCR4 expression and the extent to which sur-
face levels of CXCR4 are regulated by endocytosis.
 
Materials and Methods
 
Reagents
 
All tissue culture reagents were from GIBCO BRL, Ltd. (Paisley, Scot-
land), and other chemicals were from Sigma Chemical Co. (Poole, England),
unless otherwise indicated. Tissue culture plastic was from Nunc (Roskilde,
Denmark), and radioactive reagents were from Amersham International
plc (Little Chalfont, England). Recombinant SDF-1
 
a
 
 was purified from 
 
E
 
.
 
coli
 
. This SDF contained an additional NH
 
2
 
-terminal methionine. How-
ever, the protein was biologically active as demonstrated by (
 
a
 
) Ca
 
2
 
1
 
 flux
assays on Fura-2–loaded SupT1 cells and CHO-CXCR4 cells; (
 
b
 
) potent
activity (10–100 pM) in a CXCR4-transfected melanophore assay; (
 
c
 
) inhi-
bition of HIV-1 entry, and (
 
d
 
) ligand-induced receptor down modulation
(see text). In addition, chemically synthesised SDF-1 (7, 45) was kindly
provided by Dr. Ian Clark-Lewis (University of British Columbia, Van-
couver, Canada).
 
Cells
 
The CD4-positive human T cell line SupT1, and a CD4
 
2
 
ve
 
 derivative of
SupT1 called BC7 (20), were maintained in RPMI-1640 containing 10%
FCS, 2 mM glutamine, 100 U/ml penicillin, and 0.1 mg/ml streptomycin
(PenStrep). CHO-K1 were maintained in DMEM F12 containing 10%
FCS, glutamine, and PenStrep as above. The rhabdomyosarcoma cell line
RD was obtained from P. Clapham (Institute of Cancer Research, Lon-
don, UK) and maintained in DME containing 5% FCS, glutamine, and
PenStrep as above. Mv-1-Lu mink cells stably expressing human CD4
(Mv-1-Lu-CD4) were obtained from the Medical Research Council AIDS
Reagents Programme (NIBSC, Potters Bar, UK) and maintained in DME
containing 10% FCS, glutamine, and PenStrep as above and 1 mg/ml
G418.
CHO-K1 cells stably expressing human CXCR4, or either CXCR4 or
CCR4 tagged at the NH
 
2
 
 terminus with an epitope (YPYDVPYASLRS)
from the influenza virus haemagglutinin (HA), have been described (20).
Mv-1-Lu-CD4 cells were transfected by electroporation with human
CXCR4 in the mammalian expression vector pTEJ8 (34), together with
pBABE-hygro (41). Clones were selected in medium containing 500 
 
m
 
g/
ml hygromycin and screened for CXCR4 expression by immunofluores-
cence using 12G5. Mv-1-Lu-CD4 cells expressing a CXCR4
 
D
 
Cyt protein
lacking 42 amino acids from the COOH-terminal cytoplasmic domain
were generated using a human CXCR4 construct in which the threonine
311 codon was replaced with a stop codon by site-directed mutagenesis.
 
Antibodies
 
The anti-CXCR4 mAb 12G5 (IgG
 
2a
 
) and the anti-CD4 mAb Q4120
(IgG
 
1
 
) were described previously (20, 29). FITC-conjugated L120 (anti-
CD4) was purchased from Becton Dickinson UK Ltd. (Oxford, UK), and
rabbit antibodies against human LAMP1 were kindly provided by Dr.
Sven Carlsson (University of Umeå, Umeå, Sweden).
12G5 and Q4120 were 
 
125
 
I labeled using Bolton and Hunter reagent.
Briefly, Bolton and Hunter reagent (0.5 mCi at 
 
z
 
2,000 Ci/mmol) was dried
onto the sides of a 1.5-ml microcentrifuge tube. Antibody (
 
z
 
650 pmol) in
50 
 
m
 
l 0.1 M borate buffer, pH 8.5, was added, the tube vortexed, and the
reaction incubated at room temperature for 20 min. The reaction was
stopped by addition of 0.2 M glycine in borate buffer and the iodinated
protein separated from the reagents by gel filtration over an Econo-pac
10DG column (Bio Rad, Hemel Hempstead, UK) eluted with PBS con-
taining 0.25% gelatine and 0.02% NaN
 
3
 
. Specific activities of 303 to 391
Ci/mmol were obtained for different iodinations. Radioiodinated proteins
were stored in small aliquots at 
 
2
 
20
 
8
 
C and were stable for up to 4 mo.
 
Binding Assays
 
Antibody binding on live cells was carried out at 4
 
8
 
C. Adherent cells, usu-
ally in 16-mm wells, were incubated with radiolabeled antibody in binding
medium (BM: RPMI-1640 without bicarbonate, containing 0.2% BSA and
10 mM Hepes, and adjusted to pH 7.4, unless indicated otherwise) for 1 to
5 h at the indicated temperatures. Subsequently, the label was removed
and the cells washed 4 times with cold BM and twice with cold PBS. The
cells were then drained, collected in 400 
 
m
 
l 0.2 M NaOH, and each well
rinsed with 400 
 
m
 
l H
 
2
 
O. The cells and washings were transferred to tubes
for 
 
g
 
 counting. Fixed cells were used for binding analysis at ambient tem-
perature (20–22
 
8
 
C) or 37
 
8
 
C. For these experiments, the cells were washed
in PBS and fixed in 3% paraformaldehyde (PFA) in PBS for 10 min at
room temperature. Subsequently, the cells were washed 4 times with PBS
and free aldehyde groups quenched with 50 mM NH
 
4
 
Cl in PBS. The cells
were again washed with PBS and then incubated with labeled antibody as
above. Protein concentrations were determined using bicinchoninic acid
(Pierce, Chester, UK).
 
Phorbol Ester and SDF-1 Mediated Down Modulation
 
Cells were incubated in BM or in BM containing phorbol ester or SDF-1
as indicated in the text. For some experiments the cells were treated with
0.5 
 
m
 
M staurosporin or with 1 
 
m
 
M calphostin C (LC Laboratories Europe,
Alexis Corporation Ltd, Nottingham, UK) for 30 min before addition of
an equal volume of medium containing SDF-1 or phorbol ester. Cells
treated with calphostin C were incubated under a fluorescent strip light
for 3 min at room temperature before incubation at 37
 
8
 
C (9). After treat-
ment, the cells were placed on ice and cooled by addition of 10 ml of ice-
cold BM. T cells were then centrifuged (1,500 rpm for 5 min), washed 
Signoret et al. 
 
Endocytosis of CXCR4
 
653
 
once in PBS, and fixed with PFA as described above. After quenching and
washing with BM the cells were labeled with 0.5 nM 
 
125
 
I-12G5 antibody
for 2 h at room temperature. Subsequently, the cells were washed twice in
BM and once in PBS, resuspended in 3 ml of PBS, layered onto a 1-ml
cushion of 5% BSA in PBS, centrifuged (1,800 rpm for 5 min), and the cell
pellets recovered for 
 
g
 
 counting. For adherent cells 12G5 binding was as
described above.
 
Endocytosis Assays
 
Endocytosis assays on adherent or suspension cells were performed essen-
tially as described (48, 49). Suspension cells were harvested by centrifuga-
tion, washed twice, and resuspended at 5 
 
3
 
 10
 
6
 
 cells/ml in 4
 
8
 
C BM con-
taining 1 nM 
 
125
 
I-12G5. The cells were placed on a rotator and antibody
bound for 2 h at 4
 
8
 
C. Subsequently, the cells were washed twice in BM to
remove free antibody, and resuspended in 37
 
8
 
C BM with or without PMA.
At the indicated times, duplicate 1-ml aliquots were removed, placed into
5 ml ice-cold BM, and the cells collected by centrifugation (1,500 rpm for 5
min). One aliquot for each pair was incubated for 5 min in cold BM ad-
justed to pH 2.0, to elute cell surface-bound antibody, and the other was
washed in BM. Subsequently, the cells were layered onto a 5% BSA cush-
ion, centrifuged, and recovered for 
 
g
 
 counting as described above.
Adherent cells were seeded in 16-mm diameter wells in either 4- or 24-
well plates and grown for 2 d to a final density of 1 to 2 
 
3
 
 10
 
5
 
 cells/well.
The cells were cooled on ice, washed with BM, and incubated with 300 
 
m
 
l
BM containing 1 nM 
 
125
 
I-12G5 for 2 h on ice. Subsequently, the free anti-
body was washed away and the cells warmed by addition of 1 ml 37
 
8
 
C BM.
At the indicated times the cells were returned to 4
 
8
 
C, the media collected,
and the cells washed with cold BM. For each time point at least four wells
were used. For half of the wells, the cells were collected directly in 400 
 
m
 
l
0.2 M NaOH and transferred to tubes for 
 
g
 
 counting (total cell-associated
activity). To determine the intracellular activity, the remaining wells were
rinsed twice with 0.5 ml of 4
 
8
 
C BM adjusted to pH 2.0, and then incubated
twice for 3 min with 1 ml of the same medium to remove cell-surface anti-
body. The cells were harvested in NaOH as above. The proportion of in-
ternalized activity for each time point was determined by dividing the
acid-resistant activity by the total cell-associated activity, and endocytic
rates were calculated by analysis of the data from the first 5 min of warm up.
 
Immunofluorescence Microscopy
 
Method One. 
 
T cells were immobilized on 13-mm poly-
 
d
 
-lysine–coated glass
coverslips, fixed and quenched as described above, and stained intact or
after treatment with 0.05% saponin for 10 min at room temperature. All
solutions were made in PBS. Antibodies were diluted in PBS containing
0.2% gelatine and, for permeabilized cells, 0.05% saponin. Cells were
incubated for 1 h with primary antibodies. Fluorescent second layer antibod-
ies were all diluted 1:2,000 in 0.2% gelatine, and incubations were for 1 h.
 
Method Two. 
 
T cells were washed twice in cold BM and labeled with 7
 
m
 
g/ml (50 nM) 12G5 for 2 h at 4
 
8
 
C. Some samples were also labeled with
FITC-conjugated L120. The cells were washed twice in cold BM. One ali-
quot of cells was kept at 4
 
8
 
C, while the others were incubated at 37
 
8
 
C in
BM with or without PMA. At the indicated times, 1 ml of cell suspension
was transferred to cold BM, centrifuged, and washed in cold BM. The cells
were fixed in 3% PFA, washed twice in PBS, and free aldehyde groups
quenched using 50 mM NH
 
4
 
Cl. The cells were attached to poly-
 
d
 
-lysine
coated coverslips, washed in PBS containing 0.2% gelatine and 0.05% sa-
ponin for 15 min, and incubated for 30 min with anti–mouse-Biotin (Am-
ersham Intl. plc) and, where indicated, antibodies against LAMP1. The
cells were washed again and stained with streptavidin conjugated to FITC
or Texas red, or Rhodamine-conjugated goat anti–rabbit antibodies
(Pierce) as appropriate. Subsequently the coverslips were mounted in Mo-
viol and examined using a microscope (Optiphot-2; Nikon, Melville, NY)
equipped with a laser scanner (MRC 1024; Bio Rad). The images were as-
sembled in and printed directly from Adobe Photoshop.
 
Flow Cytometry
 
Expression of cell surface antigens was analyzed using a FACSCalibur
 
®
 
flow cytometer (Becton Dickinson). Briefly, cells were centrifuged (2,000
RPM
 
 
 
for 5 min), resuspended in ice cold PBS containing 0.1% BSA and
0.02% NaN
 
3
 
, and incubated with 50 nM 12G5 for 30 min at 4
 
8
 
C. Subse-
quently, the cells were incubated with FITC- or PE-conjugated F(ab)
 
9
 
2
 
goat anti–mouse IgG (Tago Laboratories, Burlingame, CA).
 
Electron Microscopy
 
T cells were collected by centrifugation (1,500 rpm for 5 min), washed
once in BM containing 1% BSA, and labeled in 50 nM 12G5 for 2 h at 4
 
8
 
C.
To determine nonspecific binding, some cells were incubated in medium
without the primary antibody. After three washes in BM/1% BSA, cells
were labeled with 10-nm protein A-gold particles (British Biocell Interna-
tional, Cardiff, UK) for an additional 2 h at 4
 
8
 
C. Cells were washed once
in BM/1% BSA and twice in BM containing 0.1% BSA and divided into
three aliquots. One sample was kept on ice. The other two were warmed
to 37
 
8
 
C for 2 min by resuspension in 37
 
8
 
C BM/0.1% BSA with or without
PMA. Subsequently, the cells were returned to 4
 
8
 
C by dilution with 10 ml
of ice-cold BM/0.1% BSA, harvested by centrifugation, and fixed in 2.5%
glutaraldehyde in 50 mM sodium cacodylate buffer, pH 7.2, containing
50 mM KCl and 2.5 mM MgCl
 
2
 
. Alternatively, fresh cells were prefixed by
mixing cell suspensions in an equal volume of double-strength fixative
(4% PFA/0.4% glutaraldehyde in 0.1 M sodium phosphate buffer, pH
7.4). After 10 min at room temperature, the cells were collected and resus-
pended gently in 2% PFA/0.2% glutaraldehyde in 0.1 M sodium phos-
phate buffer, pH 7.4, for an additional 80 min. Cells were washed and
quenched overnight in PBS containing 1% BSA and 50 mM glycine be-
fore staining with 50 nM 12G5 for 2 h at room temperature, followed by
protein A-gold for 2 h. After postfixation in osmium tetroxide, cells were
stained in Kellenberger’s uranyl acetate, dehydrated, and embedded in
Epon. Ultrathin sections were examined using a transmission electron mi-
croscope (EM 400; Phillips, Eindhoven, The Netherlands).
 
HIV-1 Infection
 
For HIV-1 infection, semi-confluent Mv-1-Lu-CD4/CXCR4 and -CD4/
CXCR4
 
D
 
Cyt cells were trypsinized, washed, and 2 
 
3
 
 10
 
4
 
 cells seeded in
each well of a 96-well plate in 200 
 
m
 
l DME with 10% FCS and cultured for
2 d before infection. The cultures were treated with SDF-1 or RANTES at
twice the indicated concentration for 30 min at 37
 
8
 
C. An equal volume of
HIV
 
IIIB
 
 diluted from a stock virus (10
 
3
 
 focus forming units) was added and
the cells cultured for 14 h before the virus and chemokine were removed.
The cells were cultured for an additional 2 d and then fixed in methanol/
acetone. They were then stained with the anti–HIV-1 Gag mAbs E67.1
and 38:96K for 1 h and subsequently with a goat anti–mouse IgG conju-
gated to 
 
b
 
 galactosidase (Seralab, Crawley Down, UK) for 1 h. 
 
b
 
 Galac-
tosidase activity was detected by incubation with 5-bromo-4-chloro-3-indolyl-
 
b
 
-D-galactopyranoside (X-Gal), and foci of blue cells were viewed by
light microscopy and counted.
 
Results
 
12G5 Binding
 
To use 12G5 as a probe for CXCR4 trafficking we initially
characterized the binding properties of this antibody on hu-
man RD and SupT1 cells constitutively expressing CXCR4
and on CHO cells expressing recombinant human CXCR4
with or without an NH
 
2
 
-terminal HA tag. In preliminary
experiments we found that on cells labeled at 4
 
8
 
C and on
cells fixed with 3% PFA and labeled at room temperature
or 37
 
8
 
C, antibody binding at 
 
z
 
K
 
d
 
 concentration was slow.
At 4
 
8
 
C it took 5 h to reach near saturation (t
 
1/2
 
 maximum
binding, 1 nM 
 
5
 
 80 min), while at both room temperature
and at 37
 
8
 
C, binding was slightly faster (t
 
1/2
 
 maximum
binding 
 
5
 
 55 min) but still required 
 
.
 
5 h to reach steady
state (not shown). Similar amounts of antibody were
bound after 5 h at all temperatures, suggesting that the
12G5 epitope was not significantly affected by aldehyde
fixation. No binding was seen on CHO cells expressing
HA-tagged CCR4 under the same conditions. Although
binding was slow, the dissociation rate for bound antibody
was also slow. On CHO-CXCR4-HA 
 
,
 
12% of the bound
antibody dissociated from the cells over 2 h at 37
 
8C (not
shown), while on BC7 cells, .80% remained cell bound
after 1 h (see Fig. 3 A).The Journal of Cell Biology, Volume 139, 1997 654
To determine the level of CXCR4 expression we incu-
bated cells with increasing concentrations of 125I-12G5 for
5 h. Even at the highest 125I-12G5 concentration used,
binding on CXCR4-HA cells was not fully saturated (Fig.
1 A), probably because these cells express relatively high
levels of the CXCR4-HA protein. Scatchard analysis of
the data indicated z1.3 3 106 antibody binding sites per
cell with a Kd of 4 nM (Fig. 1 B). Similar analysis of BC7
cells indicated 50,000–100,000 binding sites with a Kd of 2
to 4 nM (not shown). Analysis of the RD cell line indi-
cated z380,000 12G5 binding sites per cell with a Kd of 2.2
nM (Fig. 1 B). HeLa cells that are permissive for T cell
line-adapted HIV-1 viruses, when transfected with CD4
(21), expressed ,60,000 12G5 binding sites (not shown).
In alternative assays using unlabeled 12G5 to compete
125I-12G5 (1 nM), binding on CHO-CXCR4-HA cells was
saturated at 20 to 30 nM 12G5 with an IC50 of 3.3 nM.
Scatchard analysis of this data indicated a single class of
binding site with a Kd of 1 nM and z106 binding sites per
cell (not shown).
Together the Kds for 12G5 binding on different cell lines
fell within the range 1–5 nM, and the iodinated antibody
and native protein had similar affinities for antigen. For sub-
sequent biochemical experiments, 125I-12G5 was used at
1 nM, unless indicated otherwise, while higher concentra-
tions of unlabeled mAb were used for morphological as-
says.
Down Modulation of Cell Surface CXCR4
Previous studies have indicated that phorbol esters can
modulate the cell surface expression of CD4 (31, 51) and
may also influence CXCR4 expression (2, 25, 26, 36). To
examine the effect of phorbol ester on CXCR4 expression
directly, we incubated SupT1 cells at 378C in the presence
or absence of 100 ng/ml PMA. After 60 min the cells were
fixed and stained with 12G5 either intact or after perme-
abilization with saponin. In the absence of PMA, clear cell
surface CXCR4 staining was seen on intact SupT1 cells
(Fig. 2 A, A). When untreated cells were permeabilized
before incubation with antibody, much of the cell surface
staining was lost, suggesting that the 12G5 epitope on
CXCR4 was sensitive to detergent. Nevertheless, some in-
ternal punctate staining was observed (Fig. 2 A, B). After
phorbol ester treatment, the cell surface staining on intact
cells was significantly decreased (Fig. 2 A, C); concomi-
tantly, the intracellular fluorescence increased markedly
(Fig. 2 A, D), suggesting that phorbol esters induced en-
docytosis of cell surface CXCR4.
To determine the extent, concentration dependence, and
kinetics of phorbol ester-induced down modulation, SupT1
and BC7 cells were incubated for 2 h in the absence or
presence of phorbol ester. The cells were then cooled, la-
beled at 48C with 12G5 and goat anti–mouse-FITC, and
analyzed by FACS. Fig. 2 B indicates that the expression
of CXCR4 was reduced by 65 and 95% on the PMA-
treated SupT1 and BC7 cells, respectively. Control experi-
ments on SupT1 cells indicated that CD4 underwent simi-
lar down modulation in the presence of PMA, but that
MHC class 1 antigens did not (data not shown). Using a
similar assay we determined that the 100 nM (60 ng/ml)
PMA gave maximal CXCR4 down modulation on SupT1
(Fig. 2 C). Routinely, 100 ng/ml PMA was used for subse-
quent experiments. The kinetics of phorbol ester-induced
down modulation showed that cell surface CXCR4 levels
decreased with a half time of z15 min for SupT1 cells (see
Fig. 8 A).
Endocytosis of CXCR4 in T Cells
The appearance of increased intracellular CXCR4 staining
after phorbol ester treatment (Fig. 2 A) suggested that
PMA-induced CXCR4 down modulation occurred through
endocytosis of CXCR4, rather than by mechanisms that al-
tered the conformation of CXCR4 at the cell surface. To
measure endocytosis directly we used 125I-12G5 in assays
previously established for CD4 (48, 49, 51). BC7 cells were
labeled with 125I-12G5 for 2 h at 48C (conditions that in-
hibit endocytosis), washed, and then warmed to 378C in
the presence or absence of PMA. Antibody remaining at
Figure 1. Binding properties of 12G5 on CXCR4-expressing
cells. (A) Concentration dependence of 12G5 binding. CHO cells
expressing CXCR4-HA (s) or CCR4-HA (m) and RD cells (d)
were incubated with increasing concentrations of 125I-12G5 (up to
10 nM) for 5 h at 48C. Aliquots of the unbound label (free) were
taken for counting and the cells washed and harvested. The pro-
tein per well was determined and used to calculate the amount of
antibody bound per 106 cells. The binding recorded on CCR4-HA
cells was taken as background and was deducted from the other
cell lines to generate the binding data used in the Scatchard anal-
ysis illustrated in B. (B) Scatchard analysis of 12G5 binding. The
bound and free 12G5 activities derived from the experiment illus-
trated in A were used for Scatchard-type analysis of 12G5 binding
to native CXCR4 expressed on RD cells (d) and CXCR4-HA ex-
pressed on CHO cells (s).Signoret et al. Endocytosis of CXCR4 655
the cell surface after the 378C incubation was removed by
briefly incubating the cells in 48C media adjusted to pH 2.0.
Control experiments indicated that .95% of the cell sur-
face mAb was eluted under these conditions (not shown).
The remaining acid-resistant, cell-associated activity was
intracellular.
In BC7 cells, bound 125I-12G5 was observed to undergo
slow (z1% of the cell surface pool/min) constitutive en-
docytosis (Fig. 3 A). Uptake reached steady state 30–60
min after warm up, when z18% of the initial cell surface
pool of antibody was inside the cells. These rates were
similar to the bulk flow internalization of cytoplasmic do-
main-deleted forms of CD4 measured previously in T cell
lines (48) and suggest that CXCR4 undergoes slow ligand-
independent internalization and recycling on these cells.
When cells were warmed in the presence of PMA, the rate
of uptake was increased by .6-fold and reached steady
state between 15 and 30 min, when z80% of the cell-asso-
ciated radioactivity was intracellular. The PMA-induced
increase in CXCR4 endocytosis was again similar to the
phorbol ester-induced endocytosis and down modulation
of CD4 (31, 32, 51) and suggests that the activation of pro-
tein kinase C can induce the exposure of one or more en-
docytosis signals in CXCR4. Very similar data were ob-
tained with SupT1 cells (not shown).
Endocytosis of CXCR4 in Transfected CHO and
Mink Cells
We also examined the properties of human CXCR4 ex-
pressed in transfected cell lines. Initially we used stable
CHO cell lines but found that these cells show fast consti-
tutive endocytosis of CXCR4 (z2.5% per min) in the ab-
sence of phorbol ester and ligand. In these cells the uptake
of radiolabeled antibody reached a peak after 30 min of
endocytosis, when 60% of the initial cell surface pool was
inside the cells (not shown). Furthermore, the uptake of
125I-12G5 was only slightly enhanced by PMA and cell sur-
Figure 2. Phorbol ester-induced down modulation of CXCR4.
(A) Immunofluorescence analysis of CXCR4 down modulation
on SupT1 cells. Cells were incubated in medium with (A, C and
D) or without (A, A and B) 100 ng/ml PMA for 60 min at 378C.
The cells were then fixed and stained with 12G5 either intact (A,
A and C) or after permeabilization (A, B and D) with saponin.
(B) SupT1 and BC7 cells were incubated in medium with (j) or
without ( ) 100 ng/ml PMA for 120 min at 378C. Subsequently
the cells were fixed and stained first with 12G5 and then with a
FITC-conjugated anti–mouse reagent. The stained cells were
analysed by FACScan® and the mean fluorescence intensity de-
termined for each sample. (C) The dose dependence for PMA-
induced down modulation of CXCR4 was determined on SupT1
cells. Cells were incubated in medium containing the indicated
concentration of PMA for 60 min at 378C. The cells were then
fixed, stained as described for B, and analyzed by FACScan®.
Down modulation was calculated from the mean fluorescence in-
tensity for each sample and compared to cells stained without pri-
mary antibody. Bar, 25 mm.
Figure 3. Endocytosis of CXCR4 in BC7 and Mv-1-Lu cells. BC7
cells in suspension (A) or confluent cultures of Mv-1-Lu-CD4/
CXCR4 cells (B) were labeled at 0 to 48C with 125I-12G5, washed,
and warmed to allow endocytosis of the ligand. The amount of in-
ternalized antibody was determined by acid washing as described
in Materials and Methods. The plots show the acid-resistant ac-
tivity as a proportion of the total cell-associated counts for cells
warmed in the absence (s) or presence of PMA (d). In A the to-
tal cell-associated activity is shown for the course of the experi-
ment (n). B ( n  and m) shows the endocytosis kinetics of
CXCR4DCyt in the absence and presence of PMA, respectively.
All data points show means and standard deviations for triplicate
samples of representative experiments.The Journal of Cell Biology, Volume 139, 1997 656
face CXCR4 expression was not significantly down modu-
lated by PMA (data not shown).
As CHO cells did not reflect the trafficking of CXCR4
observed on T cell lines, we investigated alternative cells
to analyze CXCR4 trafficking. CXCR4-transfected Mv-
1-Lu-CD4 cells, a nonpolarized mink epithelial cell line,
showed properties similar to those of T cells. When CXCR4
was stably expressed in these cells, we observed slow con-
stitutive endocytosis of CXCR4 at z1% of the cell surface
pool per minute. When phorbol ester was added to the me-
dium, the rate of endocytosis increased 3–4-fold (Fig. 3 B).
At steady state, z60% of the initial cell surface pool of
125I-12G5 was intracellular. In these cells we examined
whether a mutant CXCR4 construct containing an early stop
codon that prevents synthesis of the last 42 amino acids of
the 45 amino acid COOH-terminal cytoplasmic domain of
the molecule was able to undergo endocytosis. CXCR4DCyt
was expressed on the cell surface at levels similar to
CXCR4 but, in contrast to the full length constructs,
CXCR4DCyt was internalized slowly (Fig. 3 B) at rates
and to levels comparable to the basal endocytosis of CXCR4.
In addition, we analyzed the endocytosis of CD4 in Mv-
1-Lu-CD4 cells expressing CXCR4 or CXCR4DCyt. In the
absence of phorbol ester, CD4 was internalized slowly
(z1% per min) on both CXCR4- and CXCR4DCyt-express-
ing cells, as reported for other transfected cells (48, 49).
Addition of phorbol ester induced rapid endocytosis of
CD4 on both CXCR4 and CXCR4DCyt cells (data not
shown), indicating that both were capable of responding to
phorbol ester and mediating endocytosis. Thus the lack of
phorbol ester-induced endocytosis of CXCR4DCyt was
due to the loss of the CXCR4 COOH-terminal domain
and not defects in the ability of these cells to mediate en-
docytosis.
Together these data indicate that the trafficking proper-
ties of CXCR4 can be variable in different cellular back-
grounds. However, for CXCR4 trafficking, transfected mink
cells showed properties similar to those of T cells. In mink
cells, CXCR4 undergoes slow constitutive endocytosis and
recycling that is markedly enhanced by phorbol ester and
likely to involve one or more endocytosis signals associ-
ated with the COOH-terminal domain of the molecule.
Constitutive and Phorbol Ester-induced Endocytosis of 
CXCR4 Occurs through Clathrin-coated Pits
To determine the route of CXCR4 endocytosis we exam-
ined the distribution of CXCR4 by immunoelectron mi-
croscopy. SupT1 and BC7 cells were labeled on ice with
12G5 and protein A-gold and either fixed directly or after
warming to 378C for 2 min in the presence or absence of
PMA. The 2 min time point was selected as the time at
which we expected to see the highest numbers of gold par-
ticles undergoing endocytosis. Thin sections were exam-
ined in the electron microscope and the distribution of
gold particles on the cell surface scored.
As indicated in Table I, some background labeling was
seen on cells labeled with protein A-gold alone. However,
particle counts on cells incubated with 12G5 and protein
A-gold indicated that the specific labeling was at least seven-
fold above background. On cells labeled with 12G5-pro-
tein A-gold and maintained at 48C, 2–3% of the gold particles
were located over invaginations of the plasma membrane
with cytoplasmic coats characteristic of clathrin (Fig. 4). On
cells warmed to 378C for 2 min, similar levels of labeling in
coated pits and coated vesicles were detected (1.4 and 2.0%
of particles for BC7 and SupT1 cells, respectively). After
warm up in media containing phorbol ester, the number of
particles associated with coated pits and coated vesicles
was increased 3–4-fold (Table I). This increase was consis-
tent with the phorbol ester-induced increase in the rate of
CXCR4 endocytosis determined biochemically (see above),
and suggested that the coated pit pathway is responsible
Table I. Cell Surface Distribution of 12G5-Protein
A-Gold–labelled CXCR4
12G5-Protein A-gold
Particles
counted Cell profiles
Particles in
coated pits
BC7 cells % 
No 1° 50 30 0
Prefix 558 52 1.3
4°C 366 30 2.5
37°C 2 mins 587 50 1.4
37°C 2 mins PMA 749 67 4.0
SupT1 cells
No 1° 16 33 0
4°C 207 20 2.8
37°C 2 mins 759 46 2.0
37°C 2 mins PMA 297 19 6.4
SupT1 and BC7 cells were labeled with 12G5 and protein A-gold either before or after
fixation (Prefix), as described in Materials and Methods. Cells labeled before fixation
were kept on ice or were warmed to 37°C in the presence or absence of PMA. Subse-
quently all cells were fixed and processed for electron microscopy. Individual gold
particles were scored at the microscope and their association with coated pits re-
corded.
Figure 4. EM immunolocalization of CXCR4 on the surface of
SupT1 and BC7 cells. SupT1 (A and B) and BC7 (C and D) cells
were labeled at 48C with 12G5 followed by protein A-gold
(PAG10) and either fixed directly (A) or warmed to 378C for 2
min in medium containing PMA (100 ng/ml; B and C). Alterna-
tively, cells were fixed in 2% paraformaldehyde/0.2% glutaralde-
hyde before labeling with 12G5 and PAG10 (D). Bars, 50 nm.Signoret et al. Endocytosis of CXCR4 657
for the majority, if not all, of the constitutive and phorbol
ester-induced endocytosis of CXCR4 in these cells. Hu-
man lymphoid cells do not express Vip21/Caveolin (47), and
no indication of particle association with noncoated invag-
inations of the plasma membrane was seen. After warm
up, gold particles were also occasionally observed in larger
vesicular structures resembling endosomes (not shown).
We observed some clustering of gold particles when
cells were stained with 12G5 and protein A-gold, although
this was variable with cell type and protein A-gold prepa-
ration. Notably, the clustering was similar in cells labeled
on ice or warmed in the presence or absence of PMA, sug-
gesting that it did not contribute to the enhanced localiza-
tion in coated pits seen with PMA. Furthermore, when
BC7 cells were fixed in PFA/glutaraldehyde before stain-
ing with 12G5 and protein A-gold, only single scattered
gold particles were observed. Of these, 1.3% were found
in coated pits, a figure similar to that found on cells stained
on ice (see above).
Phorbol Ester Down Modulated CXCR4 Is Located in 
Endosomes
To determine where the antibody, and hence CXCR4, was
located, we visualized 12G5 in SupT1 cells using indirect
immunofluorescence and confocal laser scanning micros-
copy. Cells were labeled with 12G5 in the cold and warmed
to 378C in the presence or absence of 100 ng/ml PMA.
Subsequently the cells were returned to 48C, fixed, perme-
abilized, and stained with anti–mouse Ig secondary re-
agents. For some experiments, cells were also labeled with
antibodies against CD4, or after fixation and permeabili-
zation, with antibodies directed against the lysosomal mem-
brane glycoprotein LAMP1.
Fig. 5 shows that when SupT1 cells were labeled at 48C
with antibodies to CD4 (green) and CXCR4 (red), both la-
bels were seen at the cell surface with overlapping, though
not completely colocalized, distributions. After warm up
to 378C in the presence of PMA, the cell surface staining
for both labels was rapidly (within 5 min) reduced, and
both labels were relocated into intracellular organelles lo-
cated in the peripheral cytoplasm and in a cluster on one
side of the nucleus. Frequently these organelles, which we
presumed to be early endosomes, were labeled for both
CXCR4 and CD4 (Fig. 5, indicated by the yellow/orange
color). After 30 min of warm up, the staining for both CD4
and CXCR4 remained overlapped, but by 120 min the de-
gree of overlap appeared to decrease, suggesting that the
CD4 and CXCR4 molecules were segregated. The major-
ity of vesicles containing 12G5 internalized for 60 min
were accessible to a pulse of FITC-dextran applied during
the final 15 min of 12G5 uptake, suggesting that CXCR4
was localized primarily to an endosome compartment (not
shown). In the absence of PMA, some punctate intracellu-
lar staining for 12G5 appeared, presumably as a conse-
quence of the constitutive endocytosis of CXCR4, but the
cell surface labeling remained prominent (not shown). Lit-
tle internalization of CD4 was observed in the absence of
PMA, in keeping with the low level of constitutive uptake
of this molecule in T cells (48, 50).
The location of intracellular CXCR4 was compared to
the distribution of LAMP1, an integral membrane glyco-
Figure 5. Immunofluorescence analysis of CXCR4 and CD4 internalization on SupT1 cells. Top figures (CD4-green/CXCR4-red):
SupT1 cells were labeled with 12G5 and FITC-conjugated L120 (anti-CD4) at 48C before warming to 378C in the medium containing 100
ng/ml PMA. At the indicated times the cells were cooled, fixed, permeabilized, and stained with a biotin-conjugated isotype-specific
anti–mouse reagent to detect 12G5, followed by streptavidin-Texas red. Lower figures (CXCR4-green/LAMP1-red): SupT1 cells were
initially labeled with 12G5 alone. After fixation and permeabilization the cells were stained with anti-LAMP1 and Rhodamine-conju-
gated anti–rabbit antibodies and with a biotin-conjugated anti–mouse reagent and streptavidin-FITC to detect 12G5.The Journal of Cell Biology, Volume 139, 1997 658
protein of late endosomes and lysosomes. After 5 min of
warm up, both in the presence or absence (not shown) of
PMA, punctate 12G5 labeling (green) was again seen in the
periphery of the cell and in a more perinuclear location as
described above. This staining appeared distinct from that
of LAMP1 (red) and for the most part remained separate
through the course of the experiment. Some overlap ap-
peared after 120 min of labeling, but it is unclear at present
whether this represents colocalization of CXCR4 and
LAMP1 or our inability to resolve spatially close but dis-
tinct LAMP1- and CXCR4-containing organelles.
In addition to the fluorescence staining, we also deter-
mined whether internalized 125I-12G5 was degraded. Anal-
ysis of TCA-soluble counts appearing in the medium indi-
cated that ,10% of the antibody initially bound to cells
was degraded after 2 h incubation at 378C (not shown).
Similar levels of TCA-soluble activity were released from
cells treated with PMA even though the intracellular level
of  125I-12G5 was increased 3–4-fold (Fig. 3). Together
these results indicated that both CD4 and CXCR4 were
internalized into endocytic organelles after phorbol ester
treatment, and that little of the internalized 12G5 antibody
was delivered to lysosomes within the time courses of
these experiments.
Internalized CXCR4 Recycles to the Cell Surface
To determine whether CXCR4 internalized in the pres-
ence of phorbol ester can recycle to the cell surface, we in-
cubated SupT1 cells at 378C in phorbol dibutyrate (PDB),
a phorbol ester that can be washed out of cells. The cells
were incubated with PDB for 60 min and then either left
with PDB for a further period, or washed and returned to
normal media for the indicated time periods. A second set
of cells was treated similarly, but cycloheximide was in-
cluded in the medium. Fig. 6 shows that incubation in PDB
down regulated 60% of CXCR4 from the cell surface, and
that CXCR4 expression remained low when the cells were
maintained in PDB for a further 90 min. However, when
the PDB-treated cells were returned to normal medium,
cell surface CXCR4 levels recovered to z80% of the ini-
tial levels over the subsequent 90 min (Fig. 6). Treatment
with cycloheximide had no apparent effect on the reap-
Figure 6. Recycling of internalized CXCR4. SupT1 cells were ei-
ther left untreated or incubated in medium containing 100 ng/ml
PDB for 60 min at 378C. Aliquots of the treated cells were placed
on ice or left in PDB for a further 90 min (190). The remaining
cells were washed three times with media to remove the PDB and
incubated in fresh 378C medium for the indicated time periods
( ). Subsequently, all cells were cooled to 48C and incubated
with  125I-12G5 to determine cell surface CXCR4 levels. In paral-
lel, a duplicate set of cells was treated in the same way with 100
mg/ml cycloheximide present throughout ( ). The data show the
means and standard deviations from triplicate samples.
Figure 7. 12G5 binding to CXCR4 in the presence of SDF-1. (A)
SupT1 cells were washed, fixed (3% PFA, 15 min), or cooled on
ice and incubated in twofold dilutions of SDF-1 for 2 h at room
temperature ( ) or 3 h at 48C ( ), respectively. The cells incu-
bated at 48C were then fixed, and all the cells were labeled with
0.5 nM 125I-12G5 for 2 h at room temperature. Subsequently, the
cells were washed and the amount of bound antibody deter-
mined. Antibody bound in the presence of SDF-1 is expressed as
a percentage of antibody bound in the absence of ligand and rep-
resents the means and SD for triplicate samples. (B) SDF-1 inhi-
bition of HIV-1 infection. Mv-1-Lu-CD4/CXCR4 (j) and Mv-
1-Lu-CD4/CXCR4DCyt ( ) were cultured in 96-well plates. The
cells were incubated with twice the indicated concentration of
SDF-1 (GlaxoWellcome) for 30 min before the addition of HIV-
1IIIB. After 14 h the virus and chemokines were removed and the
cells incubated for a further 2 d. Finally, the cells were fixed and
stained for infected cell foci and each focus scored as a single in-
fection event. The number of focus-forming units per 100 ml of vi-
rus innoculum is plotted on the y axis. The bars show the means
of two wells; the error bars are one standard deviation.Signoret et al. Endocytosis of CXCR4 659
pearance of CXCR4 on the cell surface, suggesting that re-
expression occurred through recycling rather than delivery
of newly synthesised CXCR4 to the plasma membrane.
This conclusion was supported by experiments in which
125I-12G5 internalized during incubation in medium con-
taining PDB was observed to recycle to the cell surface
when the PDB was removed (not shown). Together these
experiments indicated that internalized CXCR4 can recy-
cle to the cell surface.
SDF-1 Does Not Compete for 12G5 Binding on T Cells
The CXC chemokine SDF-1 was recently identified as the
native ligand for CXCR4 (7, 45). To determine whether
SDF-1 competes with 125I-12G5 for binding, SupT1 cells
were pre-incubated with SDF-1 either at 48C or, after fixa-
tion, at room temperature and then incubated with 125I-12G5
in the presence of SDF-1. At SDF-1 concentrations up to 2
mg/ml (250 nM), there was a slight (,30%) reduction of
12G5 binding on fixed cells incubated at room tempera-
ture but ,10% reduction on cells incubated at 48C (Fig. 7
A). 12G5 can partially inhibit SDF-1–mediated chemotac-
tic responses, SDF-1–induced modulation of intracellular
calcium, and SDF-1 binding to CXCR4 (8, 30). However,
on SupT1 cells at least, SDF-1 did not efficiently compete
for 12G5 binding.
The preparations of SDF-1 used for these experiments
were tested for their abilities to elicit a Ca21 flux in Fura-
2–loaded SupT1 and CHO-CXCR4 cells. Both prepara-
tions of SDF-1 produced a rapid, transient increase in cy-
tosolic free calcium, at 4 mg/ml (500 nM) as previously re-
ported (7, 45; data not shown). We also examined the
ability of SDF-1 to inhibit HIV-1 infection of Mv-1-Lu-CD4
cells expressing either CXCR4 or CXCR4DCyt. These cells
can be infected with HIV-1 when induced to express both
CD4 and an appropriate chemokine coreceptor (21). Be-
fore infection the cells were treated for 30 min with SDF-1
as indicated (Fig. 7 B) and then challenged with infectious
HIV-1IIIB. The cells were cocultured with virus overnight,
washed, and then incubated for a further 2 d. Subsequently,
the cells were fixed and stained for HIV-1 Gag. Fig. 7 B
shows  that HIV-1 infection of Mv-1-Lu-CD4/CXCR4 cells,
as indicated by the numbers of stained foci, was virtually
completely blocked in the presence of 500 nM SDF-1. Less
effective inhibition was seen with lower SDF-1 concentra-
tions. The b chemokine Rantes, which does not bind CXCR4,
had no effect on infection. The CXCR4 DCyt molecule
was also able to support HIV-1 infection in these cells (Fig.
7  B). However, infection of Mv-1-Lu-CD4/CXCR4DCyt
cells was only inhibited z60% at 500 nM SDF-1 (Fig. 7 B).
SDF-1 Down Modulates CXCR4
For chemokine receptors CXCR1, CXCR2, and CCR1,
the presence of ligand initiates both signaling responses
and rapid internalization of the cell surface receptor (11,
61). To determine whether SDF-1 induced endocytosis of
its receptor, SupT1 cells were incubated in 500 nM SDF-1
for up to 60 min at 378C. At the indicated times the cells
were transferred to ice, fixed, and labeled with 125I-12G5
to determine the level of cell surface CXCR4. Fig. 8 A
shows that incubation in SDF-1 induced a rapid (50% in 5
min) down modulation of cell surface CXCR4, with only
20% of the initial cell surface levels remaining by 30 min
of treatment. Although, we found that SDF-1 did not sig-
nificantly inhibit 12G5 binding (Fig. 7 A), we repeated
these experiments using the acid wash protocol (described
above) to remove the surface-bound SDF-1 and obtained
the same result (see below).
The concentration dependence of SDF-1–mediated
CXCR4 down modulation was determined by incubating
SupT1 cells in increasing dilutions of SDF-1 for 30 min.
The cells were then cooled on ice, fixed, and labeled with
125I-12G5. Fig. 8 B shows that maximum down modulation
was induced at SDF-1 concentrations .125 nM. Partial
down modulation was seen with lower concentrations.
Similar binding was seen whether or not the cells were
acid stripped before antibody labeling (Fig. 8 B).
To compare the down modulation induced by SDF-1
and phorbol ester, we treated SupT1 cells with 100 ng/ml
PDB in parallel to cells treated with SDF-1. As indicated
in Fig. 8 A, PDB induced down modulation of cell surface
CXCR4 expression, though the time course (50% in z15
min) was slower than that seen with chemokine. Recently,
there has been interest in the notion that CXCR4 and
CD4 associate on the cell surface and that the HIV-1 Env
is able to interact with complexes of these molecules (36).
In the phorbol ester experiments described above we ob-
served that CD4 and CXCR4 were co-internalized into
common early endosomes (Fig. 5). To determine whether
SDF-1 could induce co-internalization of CD4, we induced
CXCR4 internalization with SDF-1 for 1 h at 378C, and
subsequently the cells were labeled either with 125I-12G5
or with an anti-CD4 monoclonal antibody 125I-Q4120. Fig.
8  C  shows that although SDF-1 could down modulate
CXCR4, it did not induce CD4 internalization.
SDF-1 also induced down modulation of CXCR4 ex-
pressed in mink cells (Fig. 9). Mv-1-Lu-CD4/CXCR4 cells
were treated with SDF-1 for periods up to 1 h. At the end
of the incubation time the cells were washed with acid me-
dium and the cell surface CXCR4 levels measured using
125I-12G5. SDF-1 induced rapid down modulation of CXCR4
on these cells (Fig. 9) with a very similar time course to
that seen in T cells (Fig. 8 A). More than 50% of the cell
surface CXCR4 was removed within 10 min of addition of
SDF-1 and z90% down modulated by 60 min. In contrast,
SDF-1 did not down modulate CXCR4DCyt expressed in
Mv-1-Lu cells (Fig. 9), indicating that the COOH-terminal
cytoplasmic domain was crucial for ligand and phorbol es-
ter-induced down modulation.
SDF-1 and Phorbol Ester-induced Down Modulation
of CXCR4 Involve Different Pathways
To determine whether similar mechanisms were involved
in ligand- and phorbol ester-mediated internalization of
CXCR4, we investigated the effect of PKC inhibitors on
down modulation. SupT1 cells were treated with either
staurosporin or calphostin C for 30 min at 378C and then
challenged with SDF-1 or PDB for 30 min at 378C. Subse-
quently, cell surface CXCR4 and CD4 levels were deter-
mined and compared to those of untreated cells and cells
treated with ligand or phorbol ester but not inhibitor. We
found that both staurosporin and calphostin C inhibited
PDB-induced down modulation of CXCR4 and CD4 (Fig.The Journal of Cell Biology, Volume 139, 1997 660
10). However, neither inhibitor blocked SDF-1–induced
down modulation of CXCR4. These data suggest that the
phorbol ester-induced down modulation of CXCR4 and
CD4 involves the action of PKC. In contrast, SDF-1–medi-
ated CXCR4 down modulation appears to be independent
of PKC activation.
Discussion
The subfamily of 7TM G protein-coupled receptors for
chemokines has been implicated in the entry of human
and simian immunodeficiency viruses into cells (for review
see 40). In humans, the chemokine receptor family cur-
rently contains 13 members with known chemokine-binding
activities. These include the receptors for the CC chemo-
kines (CCR1–8), the receptors for the CXC chemokines
(CXCR1–4), and the Duffy antigen that binds both CC
and CXC chemokines (52, 54). In addition, a number of
other CCR and CXCR family members have been identi-
fied, both from cellular sources (44, 65) and in viral ge-
nomes (see for example 4), for which the ligand-binding
specificities are less well characterized or unknown. Of the
well characterised receptors, CCR5 in conjunction with
CD4 appears to be the principal coreceptor for macrophage
tropic isolates of HIV-1 (40), whereas CXCR4 is used by
T cell tropic and T cell line-adapted strains of HIV-1 (7, 21)
and either in conjunction with, or independently of, CD4
by some strains of HIV-2 (20, 55). Other family members
may also mediate entry for particular isolates of HIV-1,
HIV-2, and SIV (40). At present, the exact role of the
chemokine receptors in viral entry remains unclear. How-
ever, it appears likely that in conjunction with CD4 they
facilitate conformational changes in the viral envelope gly-
coprotein that leads to fusion of the viral membrane with
the plasma membrane of the target cell (40).
Chemokine receptors are expressed widely on lymphoid
cells and have been implicated in the chemotactic recruit-
ment of lymphocytes, neutrophils, and other leukocytes to
Figure 8. SDF-1- and PDB-induced down modulation of CXCR4 on SupT1 cells. (A) SupT1 cells were incubated in medium (u), me-
dium containing 100 ng/ml PDB (d), or medium containing 500 nM SDF-1 (e) for up to 60 min at 378C. At the indicated time points,
aliquots of cells were placed on ice, washed with cold binding medium, fixed, and incubated with 0.5 nM 125I-12G5 for 2 h at room tem-
perature. The values indicate the means and standard deviations for triplicate samples from a representative experiment. (B) SupT1
cells were incubated in twofold dilutions of SDF-1 for 30 min at 378C. The cells were then cooled to 48C and either fixed and labeled as
in A with 125I-12G5 for 2 h ( ), or briefly incubated in low pH medium before fixation and labeling ( ). (C) SupT1 cells were incu-
bated with (j) or without ( ) 125 nM SDF-1 for 60 min at 378C. The cells were then cooled to 48C, fixed, and labeled as in A with 125I-
12G5 or 0.3 nM 125I-Q4120 to detect cell surface CXCR4 and CD4, respectively.
Figure 9. The COOH-terminal cyto-
plasmic domain is required for SDF-1
down regulation of CXCR4. Mv-1-Lu-
CD4/CXCR4 and Mv-1-Lu-CD4/
CXCR4DCyt were incubated in BM
(u) or BM containing 500 nM SDF-1
(s) at 378C. At the indicated times the
cells were cooled on ice, washed with
BM, and then incubated in BM ad-
justed to pH 2.0 (acid medium) for 10
min. The cells were then returned to
BM (pH 7.4) at 48C and cell surface
CXCR4 determined using 0.5 nM 125I-
12G5. Each point shows the mean and
SD of triplicate samples from a repre-
sentative experiment.Signoret et al. Endocytosis of CXCR4 661
sites of inflammation (54). Significantly, the chemokine
ligands for CCR5 (MIP-1a, MIP-1b, and Rantes), CCR3
(Eotaxin), and CXCR4 (SDF-1), as well as some receptor
antagonists, can inhibit infection of cells by HIV viruses
that use these receptors (3, 60). Studies with other 7TM
proteins, and with IL-8 receptors (CXCR1 and 2) in par-
ticular, have indicated that ligand binding can induce rapid
internalization and down modulation of the receptors
from the cell surface (11, 22, 56, 61). Therefore, chemo-
kines could exert their antiviral effects by sterically block-
ing binding of viral Env or by inducing internalization of
the chemokine receptor. To understand the cellular mech-
anisms that regulate the surface expression of CXCR4,
and thus its ability to function as an HIV coreceptor, we
used the CXCR4-specific monoclonal antibody 12G5 (20)
to evaluate CXCR4 endocytosis in response to phorbol es-
ter and its natural ligand, SDF-1.
We found that CXCR4 on T cell lines undergoes slow
constitutive endocytosis and recycling. The rate of inter-
nalization was z1% of the cell surface pool per minute
and reached steady state in 30 to 60 min, when z20% of
the initial surface pool was intracellular. EM analysis of
cells labeled with 12G5 and protein A-gold indicated that
z1–2% of cell surface CXCR4 was associated with coated
pits under these conditions. When SupT1 or BC7 cells were
treated with phorbol esters, the cell surface expression of
CXCR4 decreased. The possibility that the change in ex-
pression was due to phorbol ester-induced conformational
changes in the protein that disrupted the 12G5 binding site
was ruled out by the demonstration that CXCR4 with as-
sociated antibody was internalized. The biochemical ex-
periments using 125I-12G5 indicated that phorbol esters
rapidly induced a sixfold increase in the rate of endocyto-
sis of CXCR4 from the cell surface, resulting in .80% of
the cell-associated radioactivity being located in intracel-
lular compartments within 30 min. Furthermore, electron
microscopy of immunogold-labeled PMA-treated cells in-
dicated that the increased endocytosis occurred through
enhanced interaction of CXCR4 with coated pits. The in-
tracellular accumulation of CXCR4 may occur through in-
creased endocytosis; in addition, inhibition of recycling
may also contribute to down modulation. We have been
unable to measure the rates of recycling in the continued
presence of ligand or phorbol ester directly and cannot at
present rule out effects on recycling. However, modelling
calculations (51) and the observation that down modula-
tion does not go to completion suggest that the increased
rate of endocytosis is primarily responsible for the ob-
served down modulation.
We previously demonstrated that CD4 endocytosis is
also modulated by phorbol esters (32, 51). CD4 internal-
ization is regulated through its association with the Src
family kinase p56lck and by the presence of an endocytosis
signal in the cytoplasmic domain of CD4. This signal is de-
pendent on phosphorylation of critical serine residues (38)
and facilitates CD4 association with coated pits leading to
endocytosis (51). The CD4 endocytosis signal involves
serine 408 and a pair of leucine residues at positions 413
and 414 (58, 59; Pitcher, C., and M. Marsh, unpublished re-
sults). This motif (SQIKRLL in CD4, where S lies within a
PKC phosphorylation site) is representative of a group of
regulated endocytosis and trafficking signals that are ac-
tive when the serine is phosphorylated but inactive when it
is not (see for example 15, 16). A similar motif (SSLKIL;
Ile can replace Leu in these signals) is present in the
COOH-terminal cytoplasmic domain of CXCR4. Whether
this sequence is involved in phorbol ester-induced endocy-
tosis and down modulation of CXCR4 remains to be es-
tablished. However, initial experiments indicate that CCR5,
which lacks this motif, is not down modulated by phorbol
esters (Hoxie, J.A., and M. Marsh, unpublished results). In
addition, in keeping with results from the IL-8 receptor
CXCR2 (53), our experiments indicate that the COOH
terminus is required for rapid phorbol ester-induced CXCR4
endocytosis.
To examine the domains of CXCR4 involved in traffick-
ing requires an appropriate cell line for transfection. In
our initial experiments we used CHO-K1 cells stably ex-
pressing CXCR4 and HA-tagged CXCR4 molecules. How-
ever, we found that CXCR4 expressed in these cells un-
derwent relatively fast constitutive endocytosis and that
CXCR4 cell surface levels and endocytic rates were not
Figure 10. Effect of PKC inhibitors on
SDF-1- and phorbol ester-induced down
modulation of CXCR4 and CD4. SupT1
cells were washed twice by centrifuga-
tion and resuspended in 6 ml of BM,
alone or with 0.5 mM staurosporin or 1
mM calphostin C, and incubated for 30
min at 378C. For each condition 6 3 1 ml
of cell suspension (z3.25 3 106 cells/
ml) were diluted 1:1 with BM or BM
containing 200 ng/ml PDB or 250 nM
SDF-1 at 378C for 30 min. The cells
were then rapidly cooled on ice by dilu-
tion with 10 ml of cold PBS, centri-
fuged, and washed once in cold PBS.
They were then fixed for 15 min in 3%
PFA, washed, and quenched in 50 mM
NH4Cl and labeled with 0.5 nM 125I-
12G5 (for CXCR4) or 0.3 nM 125I-Q4120 (for CD4) for 2 h at room temperature. The cell-associated activity was determined as de-
scribed in Materials and Methods. Binding medium alone (u), 100 ng/ml PDB ( ), and 125 nM SDF-1 (j).The Journal of Cell Biology, Volume 139, 1997 662
significantly modified by phorbol ester. We have previ-
ously found that the constitutive endocytosis of CD4 sta-
bly expressed in CHO cells is faster than that seen in other
cell types (M. Marsh, unpublished results). As an alterna-
tive to CHO cells we analyzed the trafficking of CXCR4
expressed in mink lung cells Mv-1-Lu (these cells are used
in our laboratory as an indicator cell line for HIV-2 infec-
tion studies as they lack 7TM coreceptors for HIV-2). In
these cells the constitutive phorbol ester and ligand-induced
trafficking of CXCR4 showed properties very similar to
those observed in T cells. However, it is perhaps important
to stress that the anomalous results we observed with CHO
cells indicate that the analysis of the trafficking properties
of these receptors in transfected cells should be approached
with caution.
The CXC chemokine SDF-1 has been identified as a
ligand for CXCR4. For a number of 7TM proteins, binding
of ligand induces rapid internalization of the receptor
through both clathrin-dependent and clathrin-indepen-
dent pathways (11, 23, 24, 27, 33, 56, 61, 63, 66), though in
some cases ligand binding does not induce internalization
(35, 46). As shown here SDF-1 can induce rapid down
modulation of CXCR4 in both transformed T cell lines
and transfected mink cells. Furthermore, this down modu-
lation does not require activation of PKC. The mechanism
through which CXCR4 endocytosis occurs is unclear. Ex-
periments with the b2 adrenergic receptor suggest that
ligand binding stimulates phosphorylation of the receptor
by b adrenergic receptor-kinases (G protein-coupled re-
ceptor kinases) and interaction with b arrestins that can
act as adaptors for clathrin-coated pits (27, 66). It is at
present unclear whether similar mechanisms operate for
CXCR4. However, our results indicate that phorbol esters
and SDF-1 operate through different intracellular signal-
ing pathways to induce CXCR4 internalization. The mech-
anism of phorbol ester-induced CXCR4 internalization
may well involve PKC-mediated phosphorylation of a
COOH-terminal domain signal similar to the endocytosis
signal in CD4. Although the COOH-terminal is also re-
quired for SDF-1–induced down modulation, PKC activa-
tion is not required for ligand-induced down modulation.
It remains to be determined whether CXCR4 contains
multiple independent endocytosis signals or whether dif-
ferent signaling pathways can activate the same endocyto-
sis signal.
Although there have been many studies on the traffick-
ing of other 7TM G protein-coupled receptors, there is
currently little data on the trafficking of the CXC and CC
chemokine receptors. Here we have shown that CXCR4 is
able to undergo efficient endocytosis after treatment of
cells with phorbol esters, and that the receptor is also
down modulated by SDF-1. In mice, SDF-1 is required for
B cell lymphopoiesis, bone-marrow myelopoiesis, and for
correct development of the heart (43). CXCR4 is known
to be expressed on various lymphocytes (8) and other leu-
kocytes (40), and SDF-1 is a potent chemokine for CD341ve
hematopoietic progenitor cells (1). In addition, the protein
is also expressed on endothelial (Hoxie, J.A., and L.F. Brass,
unpublished observations) and neuronal cells (30), though
it is unclear whether it has similar functions on these cells.
For T cells at least, it is perhaps significant that CXCR4
appears to respond to similar modulatory signals as CD4.
CD4 down modulation can be induced by antigen and
other stimuli and involves the activation of PKC (38). Co-
modulation of CXCR4 together with CD4 may play a role
in regulating the activity of CD4 positive T cells. By immu-
nofluorescence we observed that CD4 and CXCR4 were
initially co-internalized into the same endosomal organelles.
However, we have no indication that the two molecules in-
teract. The different constitutive endocytosis rates of CD4
and CXCR4 expressed on SupT1 cells (48), the absence of
comodulation of CXCR4DCyt with CD4 on phorbol ester-
treated Mv-1-Lu cells, and the selective SDF-1–induced
down modulation of CXCR4 but not CD4, suggest these
two proteins do not normally form stable associations. Thus
the comodulation of CD4 and full length CXCR4 seen af-
ter phorbol ester treatment most likely occurs as a conse-
quence of the two molecules containing similar trafficking
signals. Moreover, the complex of CD4, CXCR4, and HIV-1
gp120 that has been proposed as an intermediate in viral
fusion (36, 62, 64) is likely to be induced by the presence of
the viral gp120 protein.
SDF-1 inhibits the entry of some T cell line-adapted
HIV viruses into cells (7, 45). Although there is currently
little data, initial studies have suggested that antagonists of
chemokine receptors that block virus entry do not induce
chemokine receptor internalization (60, 61), indicating that
the chemokines may be able to interfere with Env binding.
However, our findings, and similar data reported by Am-
ara et al. (2), indicate that SDF-1 can induce rapid endocy-
tosis of CXCR4, and that this chemokine is a more effective
inhibitor of HIV-1 infection on cells expressing endocyto-
sis-competent CXCR4 than on cells expressing CXCR4
DCyt, suggest that endocytosis may make a significant con-
tribution to chemokine protection. The potential to down
regulate the cell surface expression of the coreceptor mol-
ecules by ligand-dependent or -independent means may
provide novel strategies for limiting HIV infection.
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